Bio Path Holdings Inc (BPTH)

[SJSTOCKSHARK]

Gp, I got out of the majority of my shares once I saw Sabby was back in. That means you will probably see a good PPS bounce.

The only catalyst I see in the near future would be if BPTH qualifies for a Russell inclusion or with another indices. Then would we have a run up, followed by a "Russell short?"

I expect additional dilution even as the employees receive their bonuses.

We now however have a potential buyer assuming good results in the combination trial with Prexigeberson, Venetoclax and Decitabine. Why would not AbbVie be interested in buying BIOPATH if our drug makes their drug more effective?

Does the fact that the FDA put a clinical hold on a clinical trial of Venetoclax for multiple myeloma (due to deaths) affect whether or not it will continue as a treatment for AML?


https://www.reuters.com/article/brief-abbvie-says-fda-placed-a-partial-c-idUSASB01D44